P1123: TEMPO: A PHASE 2, RANDOMIZED, OPEN‐LABEL, 2‐ARM STUDY COMPARING TWO INTERMITTENT DOSING SCHEDULES OF DUVELISIB IN SUBJECTS WITH INDOLENT NON‐HODGKIN LYMPHOMA (INHL)

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 1013 - 1014
Main Authors Vorobyev, V., Yoon, D. H., Kaźmierczak, M., Grosicki, S., Tarella, C., Genua, A., Kim, J. S., Cohan, D., Daugherty, M., Flinn, I. W., Zinzani, P. L., Gordon, L. I.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000847360.49139.75